April 30th 2025
A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.
April 22nd 2025
A survey study takes a closer look into which medications patients would like to have deprescribed, along with the reasons and factors influencing that decision.
April 21st 2025
The Carlsbad plant is expected to accelerate both the development and commercialization of cell therapies.
April 15th 2025
Access USA converges in Philadelphia to explore new—and needed—solutions to boost patient outcomes.
A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.
The Future State of Oncology: The Rise of Oncology Home Care
While there are still hurdles to overcome along the way, home healthcare could deliver better patient-centered cancer care, providing improved patient outcomes, enhanced quality of life, and reduced strain on resources.
LogiPharma USA 2023: Jenifer Smith Talks About Direct Relief
Direct Relief executive provides more information about the company.
Navigating Health Insurance Coverage for Innovative and Specialty Drugs: Q&A With Maria Kirsch, President of Patients Services at EVERSANA
Kirsch discusses the complexity of the drugs and the verification process, along with Eversana’s new platform, ACTICS eAccess.
Making Sustainable Omnichannel Change
A look into ways to approach change management using three factors.
Time to Ax Copay Accumulators?
These programs can negatively impact patients trying to reach their deductible.
The Alter Pharma Group to Rebrand as A.forall
Pharmaceutical product distributor continues goal of delivering safe and affordable medication to patients.
MDCalc Launches New Commercial Division
Company brings aboard former Pfizer exec as life sciences COO in effort to help further improve patient outcomes.
Mahana Therapeutics, Bayer Strike Commercialization Deal
Collaboration to focus on digital therapeutics.
Indegene Launches Invisage, a New Omnichannel Sales and Marketing Platform
Program designed to aid life science organizations in improving go-to-market strategy.
AFP Caution Flag for Patients
While an option for financial assistance, patients should consider the challenges.
Doubling Down on Drug Adherence
Creating a user-centric approach that harnesses both digital tools and behavioral science is key to getting—and maintaining—patients on therapy, and improving clinical, financial, and, ultimately, brand-success outcomes for pharma manufacturers.
Exploring Uses of RFID Technology
Offer potential to improve patient care, including in medication adherence.
Patient Assistance Programs Pharmacy Options
Choosing the right pharmacy to administer the program involves a number of factors.
Patient Centricity in the Pharma Supply Chain
The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.
ParcelShield, Triose Establish Supply Chain Visibility Partnership
Agreement is expected to help improve the medication delivery process for patients.
Addressing Rx Affordability
The Medicare Part D cap in 2025 won’t solve patients’ need for financial assistance.
Healthcare Consulting Services Provider to Offically Be Known as AscellaHealth
Company delivers additional supply chain logistics and distribution experience to specialty pharmaceutical market.
AmerisourceBergen Launches Cell and Gene Therapy Integration Hub
The platform agnostic CGT hub hopes to streamline the path-to-care process, by providing physicians and patient services teams with visibility across the therapy development and delivery process.
Six Steps to Driving Patient Support Program Enrollment
Although there is no ‘one size fits all’ solution, the process is influenced by factors such as lifestyle stage, competitive outlook, and market constraints.
Pediatric Medicine: Challenges Abound
Innovation and investment in advancing lifesaving therapies for pediatric patients to the commercial stage remains a daunting task, but rapid advances today in modeling and simulation are reducing the hurdles for drugmakers.
High-Tech Hubs and Specialty Pharma
With the rapid rise of the specialty drug market, manufacturers are increasingly relying on new advances used by patient hubs to boost their levels of patient engagement.
What is a Digital Hub in 2023?
Deciphering the different "technology-first” and “technology-enabled” patient support programs.
Patient Hubs in an Omnichannel World
How personalized interventions can help boost the omnichannel experience for patient hubs—and drive engagement and impact adherence in outcomes.
PAP 2023: A Summary of Unparalleled Strategies to Drive Access and Affordability
Pharma Commerce offers a synopsis of some of the conference’s events.
PAP 2023: Where Patient Access and Adherence Meet Regulatory Policy
Pharma Commerce provides a look into a few of the conference’s highlights.
Jessica Longo Discusses the Changing Patient Access Landscape
Jessica Longo offers her insights on the changing patient access landscape.
Jessica Longo Discusses Support for Cardiometabolic Patients
Novo Nordisk executive dives into supporting cardiometabolic patients within her current role.
PAP 2023: Diana Villanova Discusses PAP Processes Becoming More Efficient
VP for TrialCard talks steps to making PAP processes more efficient.
PAP 2023: Diana Villanova Discusses Key Takeaways Best Practices and Industry Standards Session at Access PAP 2023
Diana Villanova explains the knowledge obtained by attendees from her breakout session.
PAP 2023: Diana Villanova Discusses Experience in Biotech Consulting with Current Role
TrialCard exec describes how her experience in biotech consulting led to her current position.